Results 31 to 40 of about 2,222,436 (336)

Covid-19 and Solid Organ Transplantation: A Review Article.

open access: yesTransplantation, 2020
The coronavirus pandemic has significantly impacted solid organ transplantation (SOT). Early in the outbreak period, transplant societies recommended suspending living kidney transplant programs in communities with widespread transmission to avoid ...
Y. Azzi   +4 more
semanticscholar   +1 more source

A Platform for Validating Colorectal Cancer Driver Genes Using Mouse Organoids

open access: yesFrontiers in Genetics, 2021
Systematic approaches for functionally validating cancer genes are needed since numerous genes mutated in cancer tissues have been identified from cancer genome sequencing.
Haruna Takeda
doaj   +1 more source

Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

open access: yesClinical Transplantation, 2019
Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the outcome of solid organ transplantation. This updated guideline from the American Society of Transplantation Infectious Diseases Community of Practice provides ...
R. Razonable, A. Humar
semanticscholar   +1 more source

Development and prevention of ischemic contracture (“stone heart”) in the pig heart

open access: yesFrontiers in Cardiovascular Medicine, 2023
Stone heart (ischemic contracture) is a rare and serious condition observed in the heart after periods of warm ischemia. The underlying mechanisms are largely unknown and treatment options are lacking.
Mei Li   +8 more
doaj   +1 more source

Guidelines for clinical diagnosis and treatment of urinary tract infection in kidney transplant recipients in China [PDF]

open access: yesXin yixue
Urinary tract infection is the most common infectious complication after kidney transplantation. To further reduce the incidence of urinary tract infection after kidney transplantation, improve the diagnosis and treatment level of urinary tract infection
Branch of Organ Transplantation of Chinese Medical Association
doaj   +1 more source

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

open access: yesGastroenterology, 2015
BACKGROUND & AIMS Nonalcoholic steatohepatitis (NASH) has been predicted to become the leading indication for liver transplantation (LT) in the United States.
R. Wong   +6 more
semanticscholar   +1 more source

Improvement of clinical and laboratory parameters in a canine with idiopathic chronic hepatitis after transplantation of allogeneic mesenchymal cells derived from bone marrow - case report [PDF]

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia
Chronic hepatitis (CH) is characterized by the replacement of hepatocytes for fibrotic tissue after injury, and treatment is not curative. Stem cell therapy has shown potential to reduce liver fibrosis.
L.G. Santos   +4 more
doaj   +1 more source

Extracellular Vesicles Derived From Adult and Fetal Bone Marrow Mesenchymal Stromal Cells Differentially Promote ex vivo Expansion of Hematopoietic Stem and Progenitor Cells

open access: yesFrontiers in Bioengineering and Biotechnology, 2021
Recently, we and others have illustrated that extracellular vesicles (EVs) have the potential to support hematopoietic stem and progenitor cell (HSPC) expansion; however, the mechanism and processes responsible for the intercellular communication by EVs ...
Corina A. Ghebes   +14 more
doaj   +1 more source

A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts

open access: yesFrontiers in Endocrinology, 2021
In recent years islet cell transplant has proven itself to be a viable clinical option for a select group of diabetic patients. Graft loss after transplant however continues to hinder the long-term success of the procedure.
Thomas Pomposelli   +6 more
doaj   +1 more source

Ex vivo anchored PD‐L1 functionally prevent in vivo renal allograft rejection

open access: yesBioengineering & Translational Medicine, 2022
Organ transplantation is the optimal treatment for patients with end‐stage diseases. T cell activation is a major contributing factor toward the trigger of rejection. Induction therapy with T cell depleting agent is a common option but increases the risk
Zihuan Luo   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy